Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
Soy it ain't so : how Trump is selling out his own voters while bailing out somebody else's
15/10/2025
JD Vance faults 'scumbag' reporters who leaked vile texts from Young Republican leaders
15/10/2025
Justice Brown Jackson flattens Louisiana lawyer in major Supreme Court redistricting trial
15/10/2025
'Do you like kids ?' Epstein accuser describes first meeting Trump in posthumous memoir
15/10/2025
